{
    "clinical_study": {
        "@rank": "55420", 
        "arm_group": [
            {
                "arm_group_label": "Cefazolin", 
                "arm_group_type": "Active Comparator", 
                "description": "intravenous, weight-based dose (1gm<80kg, 2gm>80kg), perioperatively"
            }, 
            {
                "arm_group_label": "Vancomycin", 
                "arm_group_type": "Active Comparator", 
                "description": "intravenous, weight-based dose (1gm<80kg, 2gm>80kg), perioperatively"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the incidence rate of infection in surgical patients\n      with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the\n      peri-operative period.\n\n      The hypothesis of this study is that patients undergoing surgical treatment for closed\n      fractures who are treated prophylactically with Vancomycin will have a lower incidence rate\n      of infection than patients who are treated prophylactically with Cefazolin."
        }, 
        "brief_title": "Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin", 
        "condition": [
            "Infection", 
            "Closed Fractures"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Fractures, Closed"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between 18 years old and 85 years old\n\n          -  Closed fracture\n\n          -  Fracture treatment plan is for one operation on one day (one surgical setting)\n\n          -  Likely to follow-up with surgeon until fracture is healed\n\n          -  Ability to understand and agree to Informed Consent\n\n        Exclusion Criteria:\n\n          -  Under 18 years old or over 85 years old\n\n          -  Open fracture(s)\n\n          -  Fracture requires multiple operations\n\n          -  Other injuries requiring operations\n\n          -  Documented allergy to Cefazolin or Vancomycin\n\n          -  Previous history of Methicillin-resistant Staphylococcus aureus infection\n\n          -  Previous surgery on the injured extremity within 1 year\n\n          -  Use of antibiotics within 2 weeks before or after injury\n\n          -  Use of antibiotics within 2 weeks before surgery\n\n          -  Unlikely to follow-up until fracture is healed\n\n          -  Unable to understand and agree to Informed Consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT01029457", 
            "nct_id": "NCT02027532", 
            "org_study_id": "09-060"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cefazolin", 
                "intervention_name": "Cefazolin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Vancomycin", 
                "intervention_name": "Vancomycin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cefazolin", 
                "Vancomycin"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chattanooga", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37403"
                }, 
                "name": "Erlanger Health System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prevention of Infection in Surgical Treatment of Closed Fractures: A Comparative Study of Cefazolin Versus Vancomycin", 
        "overall_official": {
            "affiliation": "UTCOM Chattanooga/Erlanger Health System", 
            "last_name": "Peter J Nowotarski, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "incidence of infection", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027532"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Tennessee", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Tennessee", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}